In two minds? Is schizophrenia a state 'trapped' between waking and dreaming?

Medical Hypotheses

Volumn 73, Issue 4, 2009, Pages 572-579

  Llewellyn, Sue ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSAPENTAENOIC ACID;

AMYGDALOID NUCLEUS; ARTICLE; AUDITORY HALLUCINATION; CHAOS THEORY; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CREATIVITY; DECLARATIVE MEMORY; DELUSION; DOPAMINERGIC SYSTEM; DREAMING; EPISODIC MEMORY; ESSENTIAL FATTY ACID DEFICIENCY; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; LONG TERM MEMORY; MEMBRANE DAMAGE; MEMORY CONSOLIDATION; NARRATIVE; NERVE CELL NETWORK; NEUROMODULATION; NEUROTRANSMISSION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOSIS; REM SLEEP; SCHIZOPHRENIA; VISUAL MEMORY;

BRAIN; DREAMS; HUMANS; MODELS, NEUROLOGICAL; SCHIZOPHRENIA; WAKEFULNESS;

EID: 69249213461     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.05.033     Document Type: Article

References (100)

1. Hobson J.A. Consciousness (1999), W.H. Freeman and Company, New York
2. Holland J.H. Emergence: from chaos to order (1998), Oxford University Press, Oxford
3. Johnson S. Emergence: the connected lives of ants, brains, cities and software (2001), The Penguin Press, Great Britain
4. Hobson J.A. Dreaming: an introduction to the science of sleep (2002), Oxford University Press, Oxford
5. Solms M. The interpretation of dreams and the neurosciences, ; 1999 [accessed 01.04.08].
6. Solms M. Dreaming: cholinergic and dopaminergic hypotheses. In: Perry E., Ashton H., and Young A. (Eds). Neurochemistry of consciousness (2002), Benjamins, Philadelphia 123-131
7. Fudge J.L., and Emiliano A.B. The extended amygdala and dopamine system: another piece of the dopamine puzzle. J Neuropsychiatry and Clin Neurosci 15 (2003) 306-316
8. Schulz W. Getting formal with dopamine and reward. Neuron 36 2 (2002) 241-263
9. LeDoux J. Synaptic self (2002), Penguin Books Ltd., England
10. Glenberg A.M. What memory is for. Behavioural and Brain Sciences 20 1 (1997) 1-55
11. Domhoff G.W. Finding meaning in dreams, a quantitative approach (1996), Plenum Press
12. Domhoff G.W., Meyer-Gomes K., and Schredl M. Dreams as the expression of conceptions and concerns: a comparison of German and American college students. Imagination, Cognition and Personality 25 3 (2006) 269-282
13. Hartmann E. Dreams and nightmares: the new theory of the origin and meaning of dreams (1998), Plenum Press
14. Clancey W.J. Conceptual coordination bridges information processing and neurophysiology. In: Pace-Schott E.F., Solms M., Blagrove M., and Harnad S. (Eds). Sleep and dreaming: scientific advances and reconsiderations (2003), Cambridge University Press, New York 130-133 [First published in the December 2000 Special Issue of Behavioural and Brain Sciences]
15. Archer M.S. Being human: the problem of agency (2000), Cambridge University Press, Cambridge
16. Walker M.P. A refined model of sleep and the time course of memory formation. Behav Brain Sci 28 1 (2005) 51-64
17. Stickgold R. Sleep-dependent memory consolidation. Nature 437 (2005) 1272-1278
18. Wagner U., Gais S., and Born J. Refinements and confinements in a two-stage model of memory consolidation. Behav Brain Sci 28 (2005) 857-858
19. Tronson N.C., and Taylor J.R. Molecular mechanisms of memory reconsolidation. Nat Rev Neurosci 8 (2007) 262-275
20. Stickgold R., and Walker M.P. Memory consolidation and reconsolidation: what is the role of sleep?. Trends in Neuroscience 28 8 (2005) 408-415
21. Stickgold R. Inclusive versus exclusive approaches to sleep and dream research. In: Pace-Schott E.F., Solms M., Blagrove M., and Harnad S. (Eds). Sleep and dreaming: scientific advances and reconsiderations (2003), Cambridge University Press, New York 223-225 [First published in the December 2000 Special Issue of Behavioural and Brain Sciences]
22. Revonsuo A. The contents of consciousness during sleep: some theoretical problems. In: Pace-Schott E.F., Solms M., Blagrove M., and Harnad S. (Eds). Sleep and dreaming: scientific advances and reconsiderations (2003), Cambridge University Press, New York 207-208 [First published in the December 2000 Special Issue of Behavioural and Brain Sciences]
23. In: Arkin A., and Antrobus J.S. (Eds). The mind in sleep (1978), Erlbaum, Hillsdale, NJ
24. Arkin A.M., and Antrobus J.S. The effects of external stimuli applied prior to and during sleep on sleep experience. In: Arkin A.M., Antrobus J.S., and Ellman S.J. (Eds). The mind in sleep: psychology and psychophysiology (1978), Erlbaum, Hillsdale, NJ 351-391
25. Cavallero C., and Cicogna P. Memory and dreaming. In: Cavallero C., and Foulkes D. (Eds). Dreaming as cognition (1993), Harvester Wheatsheaf, New York
26. Cavallero C., Foulkes D., Hollified M., and Terry R. Memory sources of REM and NREM dreams. Sleep 13 (1990) 449-455
27. De Koninck J.M., and Koulack D. Dream content and adaptation to a stressful situation. J Abnorm Psychol 84 (1975) 250-260
28. Domhoff B., and Kamiya J. Problems in dream content study with objective indicators: a comparison of home and laboratory dream reports. Arch Gen Psychiatry 11 (1964) 519-524
29. Foulkes D. Dreams of the male child: four case studies. J Child Psychol Psychiatry 8 (1967) 81-98
30. Foulkes D., and Rechtschaffen A. Presleep determinants of dream content: effects of two films. Percept Mot Skills 19 (1964) 983-1005
31. Goodenough D.R., Witkin H.A., Koulack D., and Cohen H. The effects of stress films on dream affect and on respiration and eye-movement activity during Rapid-Eye-Movement sleep. Psychophysiology 12 (1975) 313-320
32. Hall C.S. Representation of the laboratory setting in dreams. J Nerv Ment Dis 144 (1967) 198-206
33. Karacan I., Goodenough D.R., Shapiro A., and Starker S. Erection cycle during sleep in relation to dream anxiety. Arch Gen Psychiatry 15 (1966) 183-189
34. Whitman R., Pierce C., Maas J., and Baldridge B. The dreams of the experimental subject. J Nerv Ment Dis 134 (1962) 431-443
35. Witkin H.A., and Lewis H.B. Presleep experiences and dreams. In: Witkin H.A., and Lewis H.B. (Eds). Experimental studies of dreaming (1967), Random House, New York
36. Fosse M.J., Fosse R., Hobson J.A., and Stickgold R.J. Dreaming and episodic memory: a functional dissociation. J Cogn Neurosci 15 1 (2003) 1-9
37. Vertes R.P., and Eastman K.E. The Case against memory consolidation in REM sleep. Behav Brain Sci 23 (2000) 793-1121
38. Solms M. Dreaming and REM sleep are controlled by different brain mechanisms. Behav Brain Sci 23 (2000) 843-850
39. Mahowald M.W., and Schenck C.H. Dissociated states of wakefulness and sleep. Neurology 42 7 (1992) 44-51 Suppl. 6
40. Llinás R., and Ribary U. Coherent 40-Hz oscillation characterizes dream state in humans. Proc Natl Acad Sci USA 90 (1993) 2078-2081
41. Llinás R., and Paré D. Of dreaming and wakefulness. Neuroscience 44 (1991) 521-535
42. Solms M., and Turnbull O. The brain and the inner world (2002), Other Press, UK
43. Ellenbogen J.M. Human relational memory requires time and sleep. Proc Natl Acad Sci USA 104 (2007) 7723-7728
44. Crick F., and Mitchison G. The function of dream sleep. Nature 304 14 (1983) 111-114
45. Hobson J.A., and Wohl H. From angels to neurons: art and the new science of dreaming (2005), Mattioli, Italy
46. Polkinghorne D. Narrative knowing and the human sciences (1988), State University of New York Press, New York
47. Kohonen T. Self-organization and associative memory. 2nd ed. (1988), Springer-Verlag, New York
48. Maquet P. The role of sleep in learning and memory. Science 294 5544 (2001) 1048-1054
49. Maturana H.R., and Varela F.J. Autopoiesis and cognition: the realization of the living (1980), D. Reidel Publishing, Holland
50. Singer W. The brain as a self-organizing system. Eur Arch Psychiatr Neurol Sci 236 (1986) 4-9
51. Varela F.G., Maturana H.R., and Uribe R. Autopoiesis: the organization of living systems, its characterization and a model. Biosystems 5 (1974) 187-196
52. Lewin R. Complexity: life at the edge of chaos. 2nd ed. (1999), Phoenix, Great Britain
53. Goodwin B. How the leopard changed its spots: the evolution of complexity (1994), Phoenix, Great Britain
54. Redfield-Jamison K. Touched with fire: manic depressive illness and the artistic temperament (1994), Free Press, USA
55. Horrobin D.F. Schizophrenia: the illness that made us human. Med Hypotheses 50 (1998) 269-288
56. Horrobin D.F. The madness of Adam and Eve: how schizophrenia shaped humanity (2001), Bantam Press, Great Britain
57. Christensen O., and Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand 78 (1988) 587-591
58. Horrobin D.F., Glen I.M., and Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 13 (1994) 195-207
59. Horrobin D.F., Manku M.S., Hillman H., Iain A., and Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 30 8 (1991) 795-805
60. Glen A.I., Glen E.M., Horrobin D.F., et al. A red cell membrane abnormality in a sub-group of schizophrenic patients: evidence for two diseases. Schizophr Res 12 1 (1994) 53-61
61. Yao J.K., van Kammen D.P., and Welker J.A. Red blood cell membrane dynamics in schizophrenia: II. Fatty acid composition. Schizophr Res 13 3 (1994) 217-226
62. Yao J.K., and Reddy R. Fatty acids and psychiatric disorders. In: Chow C.K. (Ed). Fatty acids in foods and their health implications (2000), Marcel Dekker, New York, NY 995-1012
63. Reddy R.D., Keshavan M.S., and Yao J.K. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naïve baseline. Schizophr Bull 30 4 (2004) 901-911
64. Shah S., Vankar G.K., Telang S.D., Ramchand C.N., and Peet M. Eicosapentaenoic acid (EPA) as an adjunct in the treatment of schizophrenia. Schizophr Res 29 1-2 (1998) 158
65. Peet M., Brind J., Ramchand C.N., Shah S., and Vankar G.K. Two double-blind placebo-controlled pilot studies of eicosopentaenoic acid in the treatment of schizophrenia. Schizophr Res 49 3 (2001) 243-251
66. Emsley R., Myburgh C., Oosthuizen M.B., and van Rensburg S.J. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159 (2002) 1596-1598
67. Peet M., and Horrobin D.F. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 36 1 (2002) 7-18
68. Richardson A.J., Easton T., and Puri B.K. Red cell plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. Eur Neuropsychopharmacol 10 3 (2000) 189-193
69. Puri B.K., Richardson A.J., Horrobin D.F., et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int J Clin Pract 54 1 (2000) 57-63
70. Berger G.E., Proffitt T.-M., McConchie M., et al. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized placebo-controlled trial. J Clin Psychiatry 68 (2007) 1867-1875
71. Amminger GP, Schaefer MR, Papageorgiou K, et al. Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double-blind randomized placebo-controlled treatment study. In: Poster presentation at the international conference of schizophrenia research, March 2007, Colorado Springs, Colorado.
72. du Bois M., Deng C., and Huang X.-F. Membrane phospholipid composition, alterations to neurotransmitter systems and schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry 29 6 (2005) 878-888
73. Gazzaniga M.S., Ivry R.B., and Mangun G.R. Cognitive neuroscience. 2nd ed. (2002), W.W. Norton & Company, London
74. Fenton W.S., Hibbeln J., and Knable M. Essential fatty acids, lipid membrane abnormalities and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47 (2000) 8-21
75. Malnoe A., Milon H., and Reme C. Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina. J Neurochem 55 (1990) 1480-1485
76. Fong T.M., and McNamee M.G. Correlation between acetylcholine receptor function and the structural properties of membranes. Biochem J 25 (1986) 830-840
77. Delion S., Chalon S., Herault J., Guilloteau D., Besnard J.C., and Durand G. Chronic dietary alpha-linolenic acid deficiency alters the dopaminergic and serotonergic neurotransmission in rats. J Nutr 124 (1994) 2466-2475
78. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148 11 (1991) 1474-1486
79. Tandon R., Taylor S.F., DeQuardo J.R., et al. The cholinergic system in schizophrenia reconsidered. Neuropsychopharmacology 21 S6 (1999) 189-202
80. Sarter M., Nelson C.L., and Bruno J.P. Cortical cholinergic transmission and cortical processing in schizophrenia. Schizophr Bull 31 1 (2005) 117-138
81. Benson K.L., and Zarone V.P. Schizophrenia. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 3rd ed. (2000), Philadelphia, PA, W.B. Saunders Company 1159-1167
82. Bymaster F.P., McKinzie D.L., and Felder C.C. New evidence for the involvement of muscarinic cholinergic receptors in psychoses. In: Silman I., Soreq H., Anglister L., Michaelson D., and Fisher A. (Eds). Cholinergic mechanisms: function and dysfunction (2004), Taylor and Francis, London
83. Gottesmann C. The dreaming sleep stage: a new neurobiological model of schizophrenia?. Neuroscience 140 (2006) 1105-1115
84. Heritch A.J. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. Schizophr Bull 16 4 (1990) 605-615
85. Carpenter W.T. A few methodological issues of note. Schizophr Bull 36 6 (2008) 1003-1005
86. Raballo A. The schizotaxic self: phenotyping the silent disposition to schizophrenia spectrum disorders. Med Hypotheses; in press.
87. Uhlhaas P.J., and Mishara A.L. Perceptual anomalies in schizophrenia: integrating phenomenology and cognitive neuroscience. Schizophr Bull 33 1 (2007) 142-156
88. Allan Hobson J. A model for madness. Nature 21 (2004) 430
89. Freud S. The interpretation of dreams. J Crick (1999), Oxford University Press, Oxford
90. Scarone S, Manzone ML, Gambini O, et al. The dream as a model for psychosis: an experimental approach using bizarreness as a cognitive marker. Schizophr Bull 2008; 34(3): p. 515-22.
91. Carpenter Jr. W.T., Strauss J.S., and Bartko J.J. Beyond diagnosis: the phenomenology of schizophrenia. Am J Psychiatry 138 7 (1981) 948-953
92. Lake C.R. Disorders of thought are severe mood disorders: the selective attention defect in mania challenges the Kraepelian Dichotomy - a review. Schizophr Bull 34 1 (2008) 109-117
93. Schiffer R.B., Rao S.M., and Fogel B.S. Neuropsychiatry. 2nd ed. (2003), Lippincott Williams & Wilkins, UK
94. Mohr S., and Huguelet P. The relationship between schizophrenia and religion and its implications for care. Swiss Med Weekly 134 (2004) 369-376
95. Brüne M. "Theory of Mind" in schizophrenia: a review of the literature. Schizophr Bull 31 1 (2005) 21-41
96. Penn D.L., Sanna L.J., and Roberts D.L. Social cognition in schizophrenia: an overview. Schizophr Bull 34 3 (2008) 408-411
97. Kay S.R., Flazbein A., and Opier L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 2 (1987) 261-276
98. Andreasen N.C. Positive and negative symptoms: historical and conceptual aspects. Mod Probl Pharmacopsychiatry 24 (1990) 1-42
99. Samuelian J.C. Incidence of the deficit form in refractory schizophrenia. Encephale 22 2 (1996) 19-23
100. Gladwell M. The tipping point: how little things make a big difference (2002), Abacus, UK